Refill competitors in the clinic ordering market

Refill's most direct competitors are other telehealth infrastructure and multi-pharmacy ordering platforms — tools that give a clinic one login across several 503A compounders and may bundle patient storefronts, assessments, or outsourced prescribing. Fizy Health maintains a public compare set at /alternatives, including Scripts, BoomRx, OnlyScripts, RxFul, White Label Rx, ApexRx, and Ironsail. Some lean toward white-label DTC telehealth, some toward EMR-plus-marketplace bundles, and some toward prescriber-first ordering with concierge fulfillment. They compete for clinics that do not want to manage pharmacy logins one at a time.

A second competitive set is the single 503A compounder and its own prescriber portal — pharmacies like Empower, Hallandale, Red Rock, Anazao, and Strive that a clinic can order from directly without an aggregation layer. These are competitors when a clinic can skip the platform entirely because one compounder covers its formulary. Fizy Health competes across both sets as a pass-through platform: it aggregates like the first group for medication ops, but targets clinics with in-house prescribers who need per-vial pricing and validation before payment rather than Refill's bundled provider network or Connect storefront.

Clinics rarely pick on brand alone. They weigh four axes. Pricing transparency: does the platform show per-vial 503A landed cost before checkout, or require demo and onboarding to confirm aggregate rates plus software fees? Refill publishes tiered software fees of roughly 1.5–5% and aggregate medication pricing; Fizy Health shows resolved landed cost in catalog and cart before you order. Validation: does the tool catch invalid SIGs, prescriber state mismatches, and stock gaps before payment? Infrastructure breadth: do you need outsourced 50-state prescribing or Refill Connect, or only pharmacy routing?

Support and onboarding: email versus in-app ticketing tied to the order; self-serve signup versus sales-led catalog access. Map any competitor against these axes and the choice gets concrete. Refill is credible when aggregate leverage, provider coverage, or Connect justify the software-fee layer. The honest reason to pick a competitor is that pricing transparency, batch checkout, or pre-payment validation matters more to how you run margin than Refill's infrastructure bundle.

Refill is not primarily a compounder, an EMR, or a payment processor — it sits between clinic and pharmacy (and optionally between clinic and outsourced MDs). Competitors that only sell 503B office-use bulk, brand Rx fulfillment, or pure pharmacy SaaS solve adjacent problems. If your evaluation is strictly "which compounder has the lowest tirzepatide vial," a direct portal or a pass-through catalog comparison may be more relevant than another infrastructure platform.

For a structured head-to-head against individual vendors — Empower, Scripts, BoomRx, and the rest — see the compare-and-switch cluster. This page stays at the landscape level so you can shortlist before you open twenty separate comparisons.